Validation of the Thrombolysis In Myocardial Infarction (TIMI) risk score for unstable angina pectoris and non–ST-elevation myocardial infarction in the TIMI III registry

This publication has 6 references indexed in Scilit:

• An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS
  European Heart Journal, 2002
• Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban
  New England Journal of Medicine, 2001
• The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI
  JAMA, 2000
• The Electrocardiogram Predicts One-Year Outcome of Patients With Unstable Angina and Non–Q Wave Myocardial Infarction: Results of the TIMI III Registry ECG Ancillary Study fn1fn1The TIMI III Clinical Centers are supported by Grant R01-HL42311 and the Data Coordinating Center by Grant R01-HL42428 from the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland. Additional support was supplied by Genentech, Inc., South San Francisco, California.
  Journal of the American College of Cardiology, 1997
• Influence of Race, Sex, and Age on Management of Unstable Angina and Non—Q-Wave Myocardial Infarction
  JAMA, 1996
• Unstable angina. A classification.
  Circulation, 1989